Analyst Ranking
Bottom 26%
#3631 out of 4871 analysts
Average Return
-8.58%
Win Rate
50%2 out of 4
Risk vs Reward
Poor
Good

Daniel Busby's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Mannkind CorpMNKD
+85.62%$14.95$2.15
2015-11-04 -
2016-11-04
Sell
Abbvie IncABBV
+30.45%$114.68$149.60
2021-05-03 -
2022-05-03
Buy

Daniel Busby Analyst Color

Get additional color on Daniel Busby's coverage of popular stocks

Daniel Busby's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Verrica Pharmaceuticals IncVRCA
2Hold$4.00N/ADowngrades
3 years ago
Endo International PLCENDPQ
1Hold$5.00N/AMaintains
4 years ago
Agile Therapeutics IncAGRX
1Buy$10,000.00N/AMaintains
4 years ago
Pfizer IncPFE
1Hold$44.00N/AMaintains
4 years ago
Mannkind CorpMNKD
2Hold$5.00N/AInitiates Coverage On
4 years ago
Abbvie IncABBV
1Buy$135.00N/AReiterates
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.